Yuvraj

FDA Approves Roche’s HPV Test for Identifying Women at Highest Risk for Cervical Cancer

Roche announced that the US Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest...

Gilead and MicroDose Therapeutx Announce License and Collaboration Agreement to Develop MDT-637

Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for...

IMS Institute Reports U.S. Spending on Medicines Grew 2.3 Percent in 2010, to $307.4 Billion

The IMS Institute for Healthcare Informatics today reported a 2.3 percent increase in spending on prescription medicines in the U.S. last year, markedly lower...

Biogen Idec Receives Positive Opinion from the CHMP and Authorisation from Health Canada on AVONEX PEN

Biogen Idec announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the...

BioSante Pharmaceuticals Announces Pancreatic and Prostate Cancer Vaccine License

BioSante Pharmaceuticals, Inc. announced it has licensed its Pancreas Cancer Vaccine and Prostate Cancer Vaccine to Aduro BioTech, a clinical-stage immunotherapy company, solely for...

Trophos presents data at the American Academy of Neurology on SMA and MS

Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology,...

Joining forces to beat cancer in Asia

Three of the world’s biggest pharma companies are joining forces to try and combat Asia’s ‘cancer epidemic’ The figures are startling: Asia-Pacific makes up...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read